Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Expert Opin Ther Targets. 2011 Sep 19;15(11):1283–1295. doi: 10.1517/14728222.2011.620607

Targeting BK (big potassium) Channels in Epilepsy

Prosper N'Gouemo 1
PMCID: PMC3219529  NIHMSID: NIHMS323382  PMID: 21923633

Abstract

Introduction

Epilepsies are disorders of neuronal excitability characterized by spontaneous and recurrent seizures. Ion channels are critical for regulating neuronal excitability and, therefore, can contribute significantly to epilepsy pathophysiology. In particular, large conductance, Ca2+-activated K+ (BKCa) channels play an important role in seizure etiology. These channels are activated by both membrane depolarization and increased intracellular Ca2+. This unique coupling of Ca2+ signaling to membrane depolarization is important in controlling neuronal hyperexcitability, as outward K+ current through BKCa channels hyperpolarizes neurons.

Areas covered

This review focuses on BKCa channel structure-function and discusses the role of these channels in epilepsy pathophysiology.

Expert opinion

Loss-of-function BKCa channels contribute neuronal hyperexcitability that can lead to temporal lobe epilepsy, tonic-clonic seizures and alcohol withdrawal seizures. Similarly, BKCa channel blockade can trigger seizures and status epilepticus. Paradoxically, some mutations in BKCa channel subunit can give rise to the channel gain-of-function that leads to development of idiopathic epilepsy (primarily absence epilepsy). Seizures themselves also enhance BKCa channel currents associated with neuronal hyperexcitability, and blocking BKCa channels suppresses generalized tonic-clonic seizures. Thus, both loss-of-function and gain-of-function BKCa channels might serve as molecular targets for drugs to suppress certain seizure phenotypes including temporal lobe seizures and absence seizures, respectively.

Keywords: Anticonvulsant, Epileptogenesis, Gain-of-function, Gene mutation, Loss-of-function, Seizures

1. Introduction

Epilepsies are disorders of neuronal hyperexcitability that are characterized by spontaneous and recurrent seizures. Seizure disorder etiologies are usually divided into idiopathic, cryptogenic and symptomatic forms. Idiopathic epilepsies are characterized by focal or generalized seizures that do not result from brain lesion or metabolic abnormality. Seizure predisposition is common in idiopathic epilepsies, and genetic defects including mutations in genes encoding for Ca2+-dependent ion channels are important in the etiology of this neurological disease. Dysregulation of Ca2+ homeostasis and Ca2+ signaling are also important factors that contribute to epileptogenesis in acquired epilepsy including temporal lobe epilepsy (TLE).

Potassium channels control the resting membrane potential and therefore play a critical role in regulating neuronal excitability. Based on their structure, biophysical characteristics, pharmacological sensitivities and physiology, K+ channels are classified as voltage-gated (Kv), inwardly rectifying, Ca2+-activated and tandem-pore K+ channels. Potassium channels contribute to the pathophysiology of a broad range of neurological disorders. In particular, inherited dysfunctions of Kv channels, KQT-like subfamily, member 2 and 3, caused by gene mutations are known to contribute to the development of common idiopathic epilepsy syndromes in humans [1]. Also important to epilepsy causation is the large conductance, voltage- and Ca2+-activated K+ (BKCa) channels, which are gated by membrane depolarization and rise in intracellular Ca2+ ([Ca2+]i) levels. This unique feature of BKCa channels signaling to membrane depolarization is important for controlling neuronal hyperexcitability as the resulting outward K+ current through these channels serves to repolarise or hyperpolarize the membrane. In addition, the exquisite sensitivity of BKCa channels to Ca2+ provides an important negative-feedback system for controlling Ca2+ entry into neurons, either by deactivating voltage-gated Ca2+ (Cav) channels or increasing the activity of the Na+/Ca2+ exchangers, thus regulating Ca2+-dependent processes.

Under physiological conditions, activation of neuronal BKCa channels contributes to action potential (AP) repolarization, gives rise to the fast afterhyperpolarization (fAHP) that follows the AP, shapes dendritic Ca2+ spikes and influences neurotransmitter release [2, for review]. Thus, activation of BKCa channels is an intrinsic inhibitory mechanism to counter membrane depolarization and the excessive accumulation of cytosolic Ca2+ that occurs during seizures. Accordingly, putative loss-of-function mechanisms of BKCa channels have been associated with TLE, as fAHP conductances (mainly mediated by BKCa channels) were reduced in epileptic patients [3]. Paradoxically, gain-of-function mutations in BKCa channel subunit genes actually contribute to the development of certain forms of idiopathic generalized epilepsy in humans [4]. Thus, both gain-of-function and loss-of-function BKCa channels are potentially important molecular targets for developing drugs to prevent epileptogenesis and suppress both temporal lobe seizures (TLS) and absence seizures.

This review summarizes our current knowledge of BKCa channel structure-function and discusses the contribution of BKCa channels gain-of-function and loss-of-function mechanisms to epileptogenic neuronal hyperexcitability, and their potential as therapeutic targets for epilepsy.

2. BKCa channels

2.1 Structure and biophysical characteristics of BKCa channels

When unitary conductance is determined from current-voltage plots in symmetrical [K+] (>100 mM), three groups of Ca2+-activated K+ channels can be distinguished: large conductance (100-300 pS; BKCa), intermediate conductance (25-100 pS; IKCa), and small conductance (2-25 pS; SKCa) channels [5, for review]. Unlike SKCa and IKCa channels, BKCa (also known as BK, Slo1, Big K+, MaxiK or KCNMA1) channels are activated by both elevated [Ca2+]i and membrane depolarization. The mechanisms of Ca2+ and voltage dependency of BKCa channels are independent, with each mechanism being able to increase the open-channel probability [6]. Under physiological conditions, BKCa channels have a low affinity for Ca2+ such that >10 μM [Ca2+]i is required for channel activation [7]. This sensitivity of BKCa channels to Ca2+ is an important negative feedback mechanism for controlling Ca2+ entry and subsequent Ca2+-dependent processes. Structurally, a minimal functional BKCa channel consists of four identical pore-forming α subunits, which determine the basic properties of unitary conductance, voltage- and Ca2+-sensitivity, and channel opening probability. In most tissues, however, the BKCa channel α subunits are associated with up to three regulatory β subunits, whose expression are rather tissue-specific.

2.1.1 Pore-forming α subunit

The BKCa channel pore-forming α-subunit is encoded by the KCNMA1 (human) or Kcnma1 (mouse) gene [8]. Like Cav channels, voltage-gated Na+ (Nav) channels and other Kv channels, BKCa channel α subunits have six transmembrane segments (S1-S6) at the short extracellular N-terminus [5]. In addition, BKCa channels have a unique hydrophobic segment (S0) that leads to an exoplasmic N-terminus and additional four hydrophobic segments (S7-S10) in the large intracellular C-terminus [9]. The K+-selective pore is located at the center of four α subunits and is surrounded by the voltage-sensing domain (S1-S4 segments) [10]. The acidic residues in S2 and S3 segments, together with basic (positively charged) residues in the S4 segment, confer voltage sensitivity to BKCa channels [10,11], and membrane depolarization causes movement of these charged residues, resulting in the opening (gating) of the K+-selective pore [6,9,11]. The pore-forming motif is a loop between S5 and S6 segments that controls channel permeation and the S6 segment is believed to serve as the major structural determinant for the channel gate [12].

The intracellular C-terminal domain contains two regulators of conductance for K+ (RCK1 and RCK2) domains and contributes to the physiological regulation of BKCa channels by Ca2+ and other intracellular stimuli [13,14,15]. The distal region (S9-S10 segments) or tail domain of the C-terminus contains the Ca2+ bowl, an aspartate-rich region that is a structural element of the RCK2 domain [13,15]. Each BKCa channel α-subunit contains two tandems RCK1-RCK2 domains [14], and the channel sensitivity to Ca2+ is determined by a “gating ring” of eight RCK domains from four assembled α subunits [13,15,16]. The BKCa gating ring has a wide central hole that allows ions to move freely between the conduction pore and the intracellular side [15]. Thus, BKCa channel gating occurs via two independent sensing mechanisms, one that is voltage-dependent in the N-terminus and the other one that is Ca2+-dependent in the C-terminus.

BKCa channels have at least one low-affinity and two high-affinity Ca2+-recognition sites. The high-affinity Ca2+ recognition sites are located in RCK1 domain [17,18] and in the Ca2+ bowl of RCK2 domain [13,15,19]. The low-affinity Ca2+ recognition site is located in the RCK1 domain, but its function has not been clearly established [17]; it is known, however, that under physiological conditions (in which [Ca2+]i is in the range of a few hundred nanomolar to tens of micromolar), the low-affinity Ca2+-recognition site(s) is not occupied by Ca2+ [20]. This observation suggests that this site could exert only a small effect (if any) in increasing the open-channel probability following an increase in [Ca2+]i.

In addition to membrane depolarization and increased [Ca2+]i, BKCa channels are also activated by intracellular Mg2+ [20,21] and the low-affinity Ca2+-recognition site in RCK1 also mediates the channel's sensitivity to Mg2+ [20,21,22]. In addition, the Ca2+ bowl in RCK2 also binds Mg2+, albeit with low-affinity [23]. BKCa channels are further regulated by intracellular H+. Although some reports have conflicted, evidence shows that unlike other Kv channels, lowering [24] or increasing [25] intracellular pH, under defined conditions, enhances or decreases BKCa channel conductances, respectively. The RCK1 domain of BKCa channel also serves as the proton sensor [26], suggesting a common sensing domain for Ca2+ and protons. Other regulatory domains sites located in the C-terminus include phosphorylation sites for c-AMP-dependent protein kinase (PKA) and protein kinase C (PKC). Phosphorylation by PKA and PKC activates and inhibits BKCa channels, respectively [27]. Thus, metabolic factors can play an important role in controlling BKCa channel activity.

The BKCa channel KCNMA1gene is subjected to alternative splicing that results in number of transcription variants. Alternatively spliced BKCa channel variants exhibit both Ca2+ and voltage sensitivity [28]. Multiple sites of alternative splicing in the KCNMA1 gene have been identified, with the majority being located within the C-terminus. Interestingly, two splice isoforms of the KCNMA1 gene are expressed in the brain including the so-called stress axis hormone-regulated exon (STREX) and ZERO variant [28,29]. Thus, STREX-containing BKCa channel splice variant has a cysteine-rich insertion that the ZERO variant lacks [28,29]. Compared to the ZERO variant, the STREX variant accelerates and slows the channel's activation and deactivation kinetics, respectively, resulting in a dramatic enhancement of BKCa channel open time [29]. Thus, STREX-containing BKCa channel splice variant exhibits biophysical characteristics that may have functional relevance, as KCNMA1 mutation that enhances BKCa conductances (gain-of-function) give rise to idiopathic generalized epilepsy [4].

2.1.2 Regulatory β subunits

Four different types of BKCa channel β subunit (called β1 trough β4) have been identified thus far, each encoded by a specific gene KCNMB1-4 (human) or Kcnmb1-4 (mouse) [30]. In non-excitable cells, a novel BKCa channel auxiliary subunit, leucine-rich repeat containing protein (LRRC26) that is unrelated to the neuronal β1–4 subunits has been identified and characterized [31]. Structurally, the BKCa channel β subunit has two membrane-spanning domains and each subunit is interposed between two adjacent α subunits [32]. Functionally, β subunits alter the gating and pharmacological sensitivity of BKCa channels, as well as their regulation by phosphorylation [33,34]. In particular, the regulatory β1 subunit enhances Ca2+ sensitivity of BKCa channels and slows the rate of channel opening, whereas β2 subunit confers fast inactivation kinetics [35,36]. The β3 subunit increases BKCa channel activity [7,36] and alternative splicing of this gene's RNA produces four distinct isoforms (β3a-d), each of which has four sequence variants (V1-V4) [37,38]. The (β3a through (β3c subunits cause partial inactivation of BKCa channels [38], whereas the β3d subunit has no obvious effect on channel gating [38]. Of the four variants in the β3 subunit family, only the V4 variant of the β3 subunit markedly alters the channel's gating properties, including its fast inactivation kinetics [37]. Finally, the brain-specific BKCa channel regulatory β4 subunit increases and decreases channel activity in high and low [Ca2+]i, respectively [7]. The β4 subunit also slows the activation and deactivation kinetics of BKCa channels [7] and decreases the channel's sensitivity to pore blockers such as charybdotoxin and iberiotoxin [34,39]. Moreover, the BKCa channel β4 subunit inhibits STREX variant channels via a Ca2+-dependent mechanism [40]. Thus, at low [Ca2+]i, the β4 subunit reduces the open probability of the STREX variant channel by slowing its activation. At intermediate and high [Ca2+]i (i.e., >5.3 μM), the β4 subunit reduces BKCa channel open probability by opposing the slow deactivation conferred by the STREX exon. In contrast to its effect on STREX variant channels, β4 subunit slows both the activation and deactivation kinetics of ZERO variant channels. Thus, it has been suggested that local Ca2+ environment in combination with ZERO or STREX variant BKCa channels will determine whether β4 subunit containing BKCa channels can contribute to shaping the AP or regulating neurotransmitter release [40].

2.2 Localization of BKCa channels in the central nervous system

2.2.1 BKCa channel α subunit

BKCa channel α subunits are ubiquitously expressed in the central nervous system (CNS), yet they are preferentially located at the terminal areas of primary projection tracts [41], which is consistent with the role of these channels in regulating neurotransmitter release. Accordingly, in the cortex and hippocampus, BKCa channel α subunits are more abundantly expressed in glutamatergic nerve terminals than in GABAergic nerve terminals [42]. BKCa channel α subunits are also present in neuronal post-synaptic compartments [43], where they contribute to AP repolarization at the soma and generate the fAHP [44]. High expression levels of α subunit protein and mRNA are present in the neocortex, olfactory system, piriform cortex and hippocampus [41,45]. BKCa channel α subunit proteins are also found in mossy fibers, the axons of dentate gyrus (DG) granule cells that innervate CA3 pyramidal neurons, and within the perforant pathway, which is the principal excitatory projection innervating the hippocampus [41]. The presence of BKCa channel α subunit proteins in CA3 and CA1 pyramidal neurons and in hippocampal projections [46] may be of pathophysiological relevance because these limbic networks contribute to TLE epileptogenesis. The BKCa channel α subunit is also moderately expressed in the cortical and basolateral nuclei of the amygdala [45,46], a limbic structure that is also implicated in the pathogenesis of TLE.

In the basal ganglia, BKCa channel α subunit proteins are highly concentrated in globus pallidus, substantia nigra pars reticulata and entopeduncular nucleus [41,45,46], where this channel may play a role in the pathophysiology of ataxia and tremors. The BKCa channels α subunit proteins are also expressed in the thalamus, hypothalamus and habenula [45,46]. Interestingly, the thalamus plays a critical role in the pathophysiology of absence epilepsy in humans. Mesencephalic nuclei, including the periaqueductal gray, which plays an important role in the networks for pain and seizures, express BKCa channel α subunit proteins, at low to moderate levels [46]. The inferior colliculus (IC), which is critical in initiating acoustically evoked generalized tonic-clonic seizures, has moderate expression of BKCa channel α subunit proteins in the central nucleus and external cortex and high expression in the dorsal cortex [46]. Finally, in the cerebellum, the Purkinje cells, molecular layers and deep nuclei as well as the interpeduncular nucleus, all express BKCa channel α subunit mRNA at high levels [46].

ZERO variant BKCa channels are abundant in the brain, whereas STREX variant channels are only weakly expressed [28]. STREX-containing BK channels are primarily present in the pituitary gland, neocortex, hippocampus and cerebellum [40]. In the hippocampus, STREX variant channels are present in the DG granule cells and in CA3 pyramidal neurons, whereas these channels exhibit a weak expression in CA1 neurons [40]. Thus, STREX variant channels may play an important role in controlling excitability of DG granule cells and CA3 pyramidal neurons.

In CNS neurons, BKCa channel α subunits are also present in the mitochondria [47]. These channels are localized in the inner membrane and found in a limited subset of mitochondria in several brain structures, including the cerebral cortex, hippocampus and cerebellum [47]. The mitochondrial BKCa (called mitoBKCa) channel is also selective for K+ and activated by both Ca2+ and voltage, and has a conductance of 260-320 pS [48]. The structure of brain mitoBKCa channels remains unknown. Nevertheless, it is possible that both neuronal membrane and mitoBKCa channels are splice variants of the same KCNMA1 gene, as this gene may undergo extensive pre-mRNA splicing [49].

2.2.2 BKCa channel β subunits

In contrast to the widely distributed BKCa channel α subunit, the four regulatory β subunits display a restricted pattern of expression [37,38]. BKCa channel β1 and β4 subunit expression seems focused to non-CNS and CNS tissues, respectively [50]. In the CNS, the expression of BKCa channel β2, β3, and β4 subunit mRNA ranges from very weak to high in various structures including the neocortex, hippocampus, amygdala, substantia nigra, thalamus, and spinal cord [7,50,51].

Co-expression of BKCa channel α and β1 subunit mRNA has been clearly demonstrated in Purkinje cells, in some brainstem nuclei and in the hypothalamus [45]. Surprisingly, no co-expression of BKCa channel α and β subunits was found in the hippocampal formation (DG, CA1-3 areas), the amygdala, and all thalamic areas except zona incerta [45]. This apparent lack of BKCa channel β subunit expression in these areas might be due to weak expression that could not be detected using in situ hybridization methods. Interestingly, both the STREX variant and the β4 subunit are present in CA3 pyramidal cells and in DG granule cells [40], and this may be of relevance in TLE pathophysiology. Of the four regulatory BKCa channel β-subunits, only β4-subunit are expressed in the inner membrane of neuronal mitochondria [51], which suggests an important role for this subunit in the mechanisms of neuroprotection or neurodegeneration.

Significant splicing of the α subunit-encoding KCNMA1 (see 2.1.1) or β subunit-encoding KCNMB3 (see 2.1.2) gene, differential tissue-specific expression of the various BKCa channel β subunits, and post-translational modification of channel subunits, all contribute to the particular BKCa channel phenotype that is expressed in a given tissue or brain region.

2.3 Regulation of BKCa channel activity

Given their role in controlling neuronal excitability, modulating BKCa channels may have clinical relevance. Many factors important to epilepsy pathophysiology, including Ca2+ and pH, regulate BKCa channel activity [52,53]. For instance, BKCa channels are activated by micromolar increases in [Ca2+]i levels. Such increases in [Ca2+]i levels are restricted to “Ca2+-nano/microdomains” in the immediate vicinity of the Ca2+ source. In the CNS, the Ca2+ that activates BKCa channels is provided primarily by Cav channels and N-methyl-D-aspartate (NMDA) receptors [45,54,55]. Indeed, BKCa channels co-localize with Cav channels, such that Ca2+ diffuse only ∼13 nanometers after entering the neuron before binding to BKCa channels [56]. The specific Cav type that interacts with BKCa channels varies from neuron to neuron and includes Cav1.2 (L-type), Cav2.1 (P/Q-type), Cav2.2 (N-type) and Cav3 (T-type), but not Cav2.3 (R-type) channels [55]. In some CNS neurons, BKCa channels that contain β2 or β4 subunits can associate with Cav1.2, Cav2.1 and Cav2.2 channels [55]. Co-localization of BKCa channels with NMDA receptors in CNS neurons [54] suggests that BKCa channels may an important role in shaping the action of glutamate and controlling its release in various brain regions. In addition to depolarization-dependent Ca2+ influx, BKCa channels also are activated by Ca2+ that is released from intracellular ryanodine-gated Ca2+ pools [57]. Whether Ca2+ released from inositol triphosphate-gated Ca2+ pools can also activate neuronal BKCa channels remains unknown. Based on their distribution, BKCa channels in the plasma membrane belong to two distinct pools, namely clustered and scattered channels, which are activated by Ca2+ release from intracellular Ca2+-gated stores and Ca2+ entry through Cav channels, respectively [58].

Membrane depolarization often leads to intracellular acidification, and many types of ion channels, including BKCa channels are sensitive to H+ exposure. Interestingly, acidification reduces the activity of BKCa channels, under high [Ca2+]i conditions [26,59,60]. This sensitivity of BKCa channels to protons may play an important role in the pathophysiology of epilepsy, as intracellular acidification in some CNS neurons is tightly coupled to seizure termination [61]. Zinc (Zn2+) is an important intracellular molecule that may play an essential role in the control of neuronal excitability, as intracellular Zn2+ ([Zn2+]i) activates BKCa channels [62]. Conversely, reduced [Zn2+]i can contribute to neuronal hyperexcitability. In TLE, recurrent mossy fibers (which project from the DG granule cells to CA3 pyramidal neurons) synapse the DG, thus facilitating the synchronous firing of the granule cells. Interestingly, vesicular Zn2+ is abundant in mossy fibers. In a model of TLE, Zn2+ released from recurrent mossy fibers is thought to contribute to DG granule cells bursting [63]. Such epileptiform activity may be due to altered sensitivity of BKCa channels to [Zn2+]i.

Numerous BKCa channel blockers and activators (i.e., openers) are used to identify these channels and study their functions. Several potent and commonly used BKCa channel blockers include tetraethylamonium (TEA), paxilline, penitrem A, charybdotoxin, iberiotoxin and quinoline. TEA has poor selectivity for BKCa channels, as it also blocks other Kv channels, including Kv7.2 and Kv7.4 channels [64]. Charybdotoxin, a peptide isolated from the venom of the scorpion Leiurus quinquestriatus, is a nonselective BKCa blocker that also blocks Kv1.2 and IKCa channels [65]. Iberiotoxin, a peptide isolated from the venon of the scorpion Buthus tamulus, the tremorgenic fungal toxins paxilline and penitrem A, and the quinoline alkaloid tetrandrine are all fairly selective for BKCa channels, but also suppress Ca2+-dependent chloride channels [66]. Paxilline blocks BKCa channels-containing β4 subunits whereas iberiotoxin exhibits low activity for these channels [34]. Interestingly, mitoBKCa channels are sensitive to both charybdotoxin and iberiotoxin [67]. Another BKCa channel blocker of interest include Slotoxin (αKTX 1.11), that was isolated from the venom of scorpion Centruroides noxius Hoffman. Slotoxin appears to selectively block the BKCa channels and can pharmacologically distinguish BKCa channel complexes containing α, α/β1 and α/β4 subunits [68]. Finally, cholesterol, an endogenous compound, inhibits BKCa channels activity by decreasing both the mean open and closed times [69].

BKCa channel activators are predicted to stabilize the neuron's resting membrane potential by increasing K+ efflux, which lead to membrane hyperpolarization and subsequently dampens neuronal excitability. Many compounds activate BKCa channels including synthetic benzimidazolone derivatives such has NS11021, biaryl amines (mefenamic and flufenamide acid), diaryl ureas (NS 1609), pyridyl amines, 3-aryloxin-doles, benzopyrans, dihydropyridines, and natural modulators such as dehydrosoyasaponin-1 and flavonoids. Among the commonly used BKCa channel activators, NS11021 is a compound of interest, as it increases the open probability of BKCa channels but does not affect Cav, Kv, or Nav channels [70].

Several endogenous factors that have been implicated in the pathophysiology of epilepsy including nitric oxide, arachidonic acid metabolites, and estradiol also modulate BKCa channel activity through G-proteins, phosphorylation or dephosphorylation. Both arachidonic acid and nitric oxide potentiate BK channel activity by slowing inactivation kinetics and enhancing channel opening, respectively [71,72]. Similarly, 17β-estradiol increases BKCa channel currents by enhancing both channel opening and the expression of both α and β4 subunits [73]. Finally, ethanol, an exogenous compound that contributes to the etiology of alcohol withdrawal seizures, activates BKCa channels by increasing their mean open time and promoting Ca2+-driven channel gating [74].

2.4 The physiological role of BKCa channels

The primarily function of BKCa channels is to generate a fAHP after contributing to AP repolarization. The BKCa channel-mediated fAHP that follows an AP controls the shape and duration of that AP, thus determining the amount of Ca2+ that enters the neuron. Following a fAHP, many neurons exhibit a prolonged AHP that is comprised of medium (mAHP) and slow (sAHP) both of which are generated by SKCa channels; moreover, the sAHP is thought to play an important role in controlling spike frequency [75]. Based on their biophysical characteristics, two functionally groups of BKCa channels have been identified, namely inactivating and non-inactivating BKCa channels. The non-inactivating BKCa channels are further classified into two types including type I and type II channels. The type I non-inactivating BKCa channels contribute to AP repolarization and the induction of the fAHP and are sensitive to charybdotoxin and iberiotoxin, whereas the type II non-inactivating BKCa channels are slowly gated, iberiotoxin-resistant channels [34,76]. The molecular correlates of type I and type II non-inactivating BKCa channels are poorly understood. Nevertheless, BKCa channels that contain β4 subunits contribute to type II non-inactivating channels [34].

BKCa channels also play an important role in regulating neurotransmitter release at CNS nerve terminals. Calcium influx into presynaptic terminal via Cav channels initiates neurotransmitter release and activates BKCa channels, which in turn inhibit the release of neurotransmitter. It has been suggested that presynaptic BKCa channels are recruited only following conditions associated with a massive [Ca2+]i accumulation in presynaptic terminals, for example during seizures [77]. Under such conditions, BKCa channels would limit depolarization-induced bursting activity by hyperpolarizing the presynaptic membrane, leading to deactivation of Nav and Cav channels, and thereby inhibiting subsequent APs. This mechanism provides a rapid inhibitory response at the presynaptic terminals that is consistent with their role as an “emergency brake” that protects against neuronal hyperexcitability and prevents seizure-related neurodegeneration [78]. Another important role for BKCa channels is to prevent excessive [Ca2+]i increases by repolarizing the membrane, deactivating Cav channels and increasing activity of the Na+/Ca2+ exchanger.

Neuronal mitochondria are an important system for sequestering [Ca2+]i. Physiologically, mitoBKCa channels are important for the K+ transport. Unlike BKCa channels in the plasma membrane, opening of mitoBKCa channels results in depolarization of the inner mitochondrial membrane, which in turn modulates the mitochondria function. MitoBKCa channels may constitute a link between cytosolic and intramitochondrial Ca2+ and mitochondrial membrane potential dependent reactions. The functional role of mitoBKCa channels is poorly understood. Nevertheless, these channels may play an important role in both buffering [Ca2+]i and neuroprotection or neurodegeneration.

In general, the activation of BKCa channel reduces neuronal excitability, an action that should dampen epileptiform bursts. However, in some neurons BKCa channel activation enhances neuronal excitability. For instance, in hippocampal CA1 pyramidal cells, BKCa channels-containing β2 subunits promote frequency-dependent AP broadening during repetitive firing, an effect that is reduced by BKCa channel blockers [76,78,79]. This effect is mediated through rapid spike repolarization and the fAHP, which may limit the inactivation of Nav channels and the activation of other slower Kv channels (such as delayed rectifier K+ channels) during interspike interval [80]. Similarly, in DG granule cells, β4 subunits are believed to prevent BKCa channels from contributing to membrane repolarization, as genetically deleting of these subunits promotes both high frequency firing and AP sharpening (or narrowing), thus reducing AHP duration [81].

2.5 The role of BKCa channels in epilepsy pathophysiology

Complex spike bursts caused by enhanced inward currents through Cav channels constitute a critical epileptogenic mechanism [52]. BKCa channel currents, which are Ca2+ dependent, oppose neuronal activity and reduce neuronal hyperexcitability that could otherwise lead to seizures. Surprisingly, blocking BKCa channels inhibits epileptiform bursting in models of acute seizures and inherited epilepsy [82]. BKCa channel blockade also inhibits bursting activity induced by elevated [Ca2+]i following Ca2+ release from intracellular Ca2+-gated pools [82]. Because BKCa channels are important in controlling neuronal excitability under normal physiological conditions, it may seem counterintuitive to postulate that BKCa channel activation might contribute to neuronal hyperexcitability. Nevertheless, such effects can occur in the presence of BKCa channels that carry a gain-of-function mutation in their a-subunits [4].

2.5.1 Clinical studies

BKCa channels were first implicated in seizure-inducing neuronal hyperexcitability when it was reported that fAHP conductances were reduced in DG granule cells obtained from surgical samples from TLE patients [3]. At the time, the mechanism(s) by which altered BKCa channels contributed to seizures include downregulation of channel expression, altered channel trafficking and insertion to the plasma membrane or a loss-of-function mutation that gives rise to nonfunctional or hypo-functional channel. However, recent evidence indicates that some mutations in the genes encoding BKCa channels give rise to a gain-of-function mechanism that is associated with human idiopathic generalized epilepsy and absence epilepsy in particular [4].

Evidence indicates that the D434G missense mutation in the α subunit KCNMA1 gene may contribute to inherited generalized epilepsy (manifesting primarily as absence epilepsy, although generalized tonic-seizures occur in some patients), which is associated with paroxysmal dyskinesia [4]. This mutation is characterized by an increase in BKCa channel's sensitivity to Ca2+, enhanced voltage- and Ca2+-dependent channel activation, increased membrane currents, and an increased channel mean open time, all of which are consistent with BKCa channels gain-of-function effect [4,36,83]. This mutation specifically alters Ca2+-dependent activation initiated at the Ca2+ binding site within the RCK1 domain [84]. Several mechanisms for how D434G mutation causes BKCa channel gain-of-function effect (and the subsequent contribution to neuronal hyperexcitability and seizures) have been suggested and include rapid repolarization of APs and relief of Nav channels inactivation, up-regulation of hyperpolarization-activated channels or inhibition of GABAergic interneurons with subsequent disinhibition of thalamocortical circuits [4]. The D434G mutation may also confer specific changes to the proprieties of the regulatory BKCa channel β subunits, thus contributing to the pathophysiology of idiopathic epilepsy. Indeed, this mutation enhances the availability of BKCa channels that contain β2 subunits, and increases the channel function (i.e., opening rate) of BKCa channels containing β1 and β4 subunits but slows rates of both channel opening and closing of BKCa channels that contain β3b subunits [35]. Interestingly, a polymorphism in the gene encoding the BKCa channel β4 subunit is associated with human TLE [85]. Thus, some BKCa channel variants that have a gain-of-function phenotype may contribute to certain forms of inherited generalized epilepsy in humans when the thalamus and thalamo-cortical circuits are involved in the pathophysiology of seizures, whereas a loss-of-function BKCa channels phenotype may be associated with TLE.

The gene encoding the regulatory BKCa β3 subunit (KCNMB3) has also been implicated in the pathophysiology of epilepsy. The KCNMB3 gene maps a region in the human chromosome 3 (3q26.3-q27) [86]. This segment is duplicated in the dup(3q) syndrome, which is characterized by congenital and neurological abnormalities, including seizures [86]. Because dup(3q) syndrome has early onset during development, the duplication of the KCNMB3 gene suggests that overexpression of this gene and the resulting increase in the β3 subunit protein levels may contribute to seizure etiology. Similarly, a susceptibility locus for idiopathic generalized epilepsy maps to the 3q26 chromosome region [87]. In humans, mutations in the KCNMB3 gene may also contribute to both neuronal hyperexcitability and seizures as a single nucleotide deletion in exon 4 (delA750) is associated with idiopathic generalized epilepsy (mostly in the form of typical absence epilepsy) [88]. Interestingly, BKCa channels containing the β3b-V4 (delA750 mutation) variant exhibit fast inactivation kinetics [38], suggesting a reduced ability of these channels to repolarize the membrane during an AP, and thus leading to neuronal hyperexcitability.

2.5.2 Experimental studies

In sharp contrast to clinical studies that suggest gain-of-function BKCa channels essentially contribute to the pathophysiology of absence epilepsy, experimental studies indicate BKCa channels gain-of-function mechanisms can also trigger TLE. Thus, BKCa channel β4 subunit knockout mice exhibit TLS associated with a gain-of-function phenotype in their BKCa channels that sharpens (narrows) APs and supports higher firing frequency in DG granule cells [81]. The mechanisms by which a gain-of-function of BKCa channels without β4 subunits triggers seizures may include i) enhanced Ca2+ sensitivity of BKCa channels, ii) reduced AHP size, iii) de novo generation of type I, fast-gated BKCa channels, or iv) limited recruitment of SKCa channels between spikes [81]. A loss of β4 subunits may also remove their inhibitory effect on STREX variant BKCa channels, leading to an increase in BKCa channel function. Interestingly, DG granule cells have the strongest expression of β4 subunits in the hippocampal formation, and upregulation of the STREX variant channels (and downregulation of ZERO variant channels) in DG granule cells are associated with TLE [89]. Thus, upregulation of STREX variant may contribute to gain-of-function BKCa channels that give rise to TLS, as this variant exhibit faster activation and slower deactivation kinetics. The DG has a very high threshold for seizure initiation and is resistant to seizure-induced neurodegeneration. Thus, neuronal BKCa channel β4 subunits may provide a molecular basis for both seizure resistance and neuroprotection.

The BKCa channel regulatory β4 subunit in the inner mitochondrial membrane may also contribute to neurprotection, as the functional role of mitoBKCa channel is in part associated with this subunit. Mitochondrial dysfunction is associated with several multiple epileptic phenotypes, including TLE [90]. The mechanisms of how neuronal mitochondrial dysfunction contributes to epileptogenesis are not fully understood. Evidence indicates that seizures can elicit both significant increases in mitochondrial Ca2+ levels and changes in mitochondrial membrane potential [91]. Neuronal mitoBKCa channels would then, be activated due to rising [Ca2+] in the matrix in response to an increase in cytosolic Ca2+, and the consequence of these channels opening is K+ efflux into mitochondria matrix, resulting in depolarization of mitochondrial inner membrane, which would then stimulate respiration. Mitochondria are a major source of reactive oxygen species (ROS), and the mitochondria-mediated catalytic removal of ROS prevents status epilepticus-induced neuronal cell loss [92]. Thus, activation of mitoBKCa channels would contribute to seizure suppression and confer neuroprotection via inhibition of ROS synthesis. Alternatively, downregulation of mitoBKCa channels would contribute to (i.e., facilitate) seizure-induced neuronal cell loss.

Seizures themselves also can confer a gain-of-function effect to BKCa channels. Accordingly, picrotoxin-induced generalized tonic-clonic seizures give rise to a BKCa channel gain-of-function that is characterized by enhanced BKCa currents and increased neuronal firing in the somatosensory (barrel) cortex [93]. Interestingly, BKCa channel blockers suppressed generalized tonic-clonic seizures in pre-sensitized animals and reversed the elevated neuronal firing that follows tonic-clonic seizures [93,94]. These findings suggest that blocking gain-of-function BKCa channels may be a potential mechanism for suppressing seizures. The extent to which seizure-induced gain-of-function BKCa channels contribute to seizure generation and the development of chronic epilepsy remains unknown.

Loss-of-function or downregulated BKCa channels may also contribute to the pathophysiology of seizures in models of inherited generalized tonic-clonic epilepsy and TLE. For instance, the severe seizure strain of genetically epilepsy-prone rats (GEPR-9), which exhibit enhanced susceptibility to acoustically evoked seizures, have reduced fAHP conductances in hippocampal CA3 neurons [95]. In line with these studies, BKCa channel current density is significantly reduced in IC neurons of the moderate seizure strain (GEPR-3) [N'Gouemo, unpublished results]. However, the reduced BKCa current density was not associated with downegulation of BKCa channel α-subunit in IC neurons of GEPR-3s [96]; thus, other mechanisms (such as phosphorylation or dephosphorylation of the channel) may account for the reduced current density. In a model of TLE, however, a downregulation of the BKCa channel α subunits was reported in the cortex and hippocampus (specifically in the mossy fibers), during the active (or chronic) phase of epilepsy [97,98]. Interestingly, BKCa channels are abundantly expressed at glutamatergic presynaptic terminals including at the mossy fibers where they can control glutamate release under conditions of excessive neuronal activity. Thus, downregulation of presynaptic BKCa channels may contribute to mossy fibers hyperexcitability and aberrant glutamate release during epileptogenesis. Finally, penitrem A, a potent blocker of BKCa channels triggers seizures and status epilepticus [99]; thus providing direct evidence that these channels are critical for controlling neuronal hyperexcitability that leads to seizures.

Acute alcohol exposure potentiates BKCa channel activity [74] that should reduce neuronal excitability and provide a basis for the neurodepressive effect of alcohol. Interestingly, an abrupt reduction or cessation of chronic alcohol consumption leads to the development of alcohol withdrawal syndrome characterized by neuronal hyperexcitability and seizures (primarily generalized tonic-clonic seizures). Because of the role that BKCa channels play in controlling neuronal excitability, these channels may contribute to the etiology of alcohol withdrawal seizures. Consistent with this hypothesis, alcohol withdrawal seizures are associated with a reduction in both BKCa channel current density and BKCa channel α-subunit expression in IC neurons (N'Gouemo, unpublished data).

Thus, the aforementioned studies provide evidence to support the notion that both gain-of-function and loss-of-function BKCa channels play important roles in the pathophysiology of epilepsy. The specific role of these BKCa channels may ultimately depend, at least, in their cellular localization, anatomical distribution, variant channel expression and seizure type.

2.5.3 BKCa channel activators and blockers as antiepileptic drugs

In humans, mutations in the BKCa channels that result in a gain-of-function phenotype have been implicated in the pathophysiology of idiopathic generalized seizures [4]. Accordingly, blocking these BKCa channels should suppress seizures. In support of this hypothesis, ethosuximide, a drug of choice for human absence epilepsy inhibits neuronal BKCa channels, in addition to its primary effect of blocking Cav3 channels [100]. Furthermore, paxilline, a BKCa channel blocker, has anticonvulsant effects in models of picrotoxin- and pentylenetetrazole-induced generalized seizures in pre-sensitized animals [94]. Interestingly, at the tested dose, paxilline did not suppress acute picrotoxin- or pentlylenetetrazole-induced generalized tonic-clonic seizures in animals that were not pre-sensitized [94]. These findings suggest the convulsant pre-sensitization may contributes to the gain-of-function effect on BKCa channels, which may serve as molecular target for the anticonvulsant effect of paxilline. Loss-of-function of BKCa channels are also associated with inherited and acquired susceptibility to generalized tonic-clonic seizures and TLE, suggesting that activating BKCa channels can provide an elegant mechanism for seizure suppression. Accordingly, zonisamide, a clinically used antiepileptic drug, activates BKCa channels in addition to other mechanisms suggesting that this pharmacological activity may contribute to some extent to its anticonvulsant effect.

3. Concluding remarks

BKCa channels are important regulators of neuronal activity and represent an intrinsic inhibitory mechanism for critically restoring normal neuronal excitability. Thus, BKCa channel activators may serve as potential anticonvulsants. However, enhanced BKCa channel function may lead to increased excitability by modifying the refractory period of the associated conductances. Furthermore, mutations in the genes encoding the BKCa subunits can give rise to BKCa channel gain-of-function phenotype resulting in neuronal hyperexcitability and seizures. Seizures themselves also can induce a gain-of-function effect in BKCa channels, as a consequence of seizure activity. Blocking BKCa channels suppresses the channel gain-of-function effect and seizures, which strongly suggest these channels, are also of therapeutic interest as drug targets. Understanding the molecular basis of how both BKCa channels gain-of-function and loss-of-function BKCa channels contribute to epileptogenesis and seizure generation may lead to developing rational therapies for certain inherited and acquired epilepsy syndrome.

4. Expert opinion (1,000 words; actual:999)

The role of BKCa channels in epilepsy pathophysiology is complex as activation of these channels can lead to both anti- and pro-epileptic activities. This dual action of BKCa channels depends on many factors including the seizure type. Emerging evidence suggests that loss-of-function mechanisms of BKCa channels are associated with inherited seizure susceptibility, alcohol withdrawal seizures, and TLE, while gain-of-function effects on BKCa channels are thought to contribute to the etiology of absence epilepsy.

Despite significant progress in managing epilepsy syndromes, approximately one-third of patients with epilepsy live with uncontrolled seizures, and unwanted side effects from antiepileptic drugs are common. One of the major challenges in the management of seizures is drug resistance, the causes of which are both multiple and complex and include a failure of the antiepileptic drugs to block inward Ca2+ and Na+ currents through Cav and Nav channels, respectively, or to enhance GABA-mediated inhibition. There is an urgent need to develop novel antiepileptic drugs based on the underlying mechanisms of neuronal hyperexcitability that may lead to both epileptogenesis and seizure generation. Thus, there is intense and growing interest in the BKCa channel loss-of-function mechanisms associated with epilepsy and the novel BKCa channel gain-of-function mechanisms that give rise to seizures, both of which can result from mutations in the gene that encodes for the channel's pore-forming α subunit. Likewise, there is intense interest in gain-of-function effect on BKCa channels that is caused by seizures themselves, as this may serve as putative mechanism in epileptogenesis.

Although the phenotype of human epilepsy that is caused by gain-of function BKCa channels seems limited to absence epilepsy, there is evidence implicating a polymorphism β4 subunit polymorphism in TLE (likely with secondary generalization), which is the most common form of refractory epilepsy in adults. All of this suggests that inhibiting gain-of-function BKCa channels is a promising means to treat some epilepsy syndromes. Interestingly, BKCa channel blockers suppress both gene mutation- and seizure-induced gain-of-function effect and these blockers exert anticonvulsant effects in models of picrotoxin- and pentylenetetrazole-induced seizures in pre-sensitized young animals. The BKCa channel gain-of-function mechanisms that lead to seizures may also include elevated extracellular [K+], which is tightly associated with neuronal hyperexcitability and seizures. Blocking BKCa channels may therefore stabilize extracellular [K+] at physiological levels and suppress seizures. Thus, gain-of-function BKCa channels along with the GABAergic system and T-type Ca2+ channels are important molecular targets underlying epileptogenesis in absence epilepsy.

Because gain-of-function BKCa channels can contribute to the pathogenesis of absence epilepsy, this raises the concern that clinically effective antiepileptic drugs which enhance BKCa channel conductances, for example zonisamide, may inappropriately affects thalamic networks activity, thereby leading to absence seizures (despite suppressing other seizure phenotypes). Thus, there is an urgent need for studies to investigate the extent to which i) selective activation of BKCa channels can suppress seizures and ii) activating BKCa channels worsens absence seizures and/or trigger additional seizure phenotypes in absence epilepsy.

There is also interest in BKCa channel loss-of-function mechanisms as downregulated BKCa channels and/or decreased channel activity are associated with neuronal hyperexcitability that can lead to seizures and epileptogenesis. To date, downregulation of BKCa channels has been associated with inherited seizure susceptibility (tonic-clonic seizures), alcohol withdrawal seizures (primarily tonic-clonic seizures) and TLE (likely with secondarily generalization). Thus, compounds that open and activate BKCa channels can be used to prevent and treat these seizures. Furthermore, presynaptic BKCa channels openers, by suppressing glutamate release and contributing neuroprotection, may have a promising in role in the management of seizure-induced lesions underlying the development of pharmacoresistant TLE.

To date, only the model of picrotoxin- and pentylenetetrazole-induced seizures in pre-sensitized young animals has sufficiently demonstrated that blocking BKCa channels suppresses seizures. Other models that would be useful for confirming this result include: animal models of acute generalized seizures (maximal electroshock) and epileptogenesis (chemical or electrical kindling; post-status epilepticus models of TLE). Future studies in relevant animal models of absence epilepsy (e.i., Genetic Absence Epilepsy Rat from Strasbourg, the Wistar Absence Glaxo from Rijwik, and the γ-hydroxybutyrate spike-and-wave model) and suitable clinical populations are needed to validate the anticonvulsant profile and potential clinical application of BKCa channel blockers. The BKCa channel β4 subunit knockout mouse is a useful model to determine the role of this subunit (and its dysfunction) in TLE. However, caution should be exercised when interpreting the relevance of this model, as knocking down the channel subunit results in a protein loss but not a production of dysfunctional protein that is the case for BKCa channel mutations that lead to inherited epilepsy in humans.

Our understanding of how BKCa channels activators and inhibitors can be used therapeutically to treat or prevent seizures and epilepsy is still in the early stages. A comprehensive structure-function analysis of gain-of-function and loss-of-function BKCa channels that leads to epileptogenesis and seizures may be helpful in designing new therapeutic strategies. Developing BKCa channel blockers (and activators) that are selective for channels containing β3 and β4 subunits would certainly help determine the extent to which these subunits might mediate antiepileptic/antiepileptogenic effects. In addition, it also would be interesting to determine whether certain BKCa channel openers that were originally developed to treat various diseases such as erectile dysfunction (3-thio-quinolines, 4-aryl-3-aminoquinolones), ischemic stroke (fluoro-oxindole,4-aryl-3-aminoquinolones) exhibit antiepileptic/antiepileptogenic effects.

This review raises the hypothesis that both gain-of-function and loss-of-function BKCa channels may contribute to epileptogenesis and seizure generation. Identification of altered BKCa channel mechanisms that lead to neuronal hyperexcitability will contribute to a better understanding of the molecular substrates for epileptogenesis and seizure generation and eventually lead to more effective strategies for treating seizures and epilepsy. Targeting BKCa channels to suppress seizures and treat epilepsy can be challenging because of both anti- and pro-epileptic activity following activation of these channels. Nevertheless, identification of diverse BKCa channel α and β subunit variants may enhance the possibility of targeting selective brain areas with selective BKCa channel openers and blockers, and therefore leading to better strategies for epileptogenesis prevention and treatment of certain seizure types and epilepsy syndromes.

Highlights Box.

  • BKCa channels are activated by both membrane depolarization and increased intracellular Ca2+.

  • Outward K+ currents through BKCa channels hyperpolarize neurons.

  • Blockage of BKCa channels can trigger seizures and status epilepticus.

  • Genetic deletion of the regulatory BKCa channel β4 subunit triggers temporal lobe seizures.

  • Mutation in the KCNMB3 gene encoding for the regulatory BKCa channels β3 subunit is associated with idiopathic generalized epilepsy.

  • Loss-of-function mechanisms of BKCa channels have been associated with temporal lobe seizures, tonic-clonic seizures and alcohol withdrawal seizures.

  • Gain-of-function mutations in BKCa channel pore-forming α subunit contribute to the development of absence epilepsy.

  • Generalized tonic-clonic seizures can confer a gain-of-function effect to BKCa channels

  • Both loss-of-function and gain-of-function BKCa channels may be potential therapeutic targets for certain epilepsy syndromes.

Acknowledgments

This work was supported by an NIH grants (NS047193 and AA020073). The author would like to thank Drs. Carl L. Faingold and Alejandro M. Dopico for advice and editorial assistance.

Footnotes

Declaration of interest: The author declares no conflict of interest.

References

  • 1.Neubauer BA, Waldeggers S, Heinzinger J, et al. KCNQ2 and KCNQ3 mutation contribute to different idiopathic epilepsy syndromes. Neurology. 2008;71:177–183. doi: 10.1212/01.wnl.0000317090.92185.ec. [DOI] [PubMed] [Google Scholar]
  • 2.Berkefeld H, Falker B, Schulte U. Ca2+-activated K+ channels: from protein complex to function. Physiol Rev. 2010;90:1437–1459. doi: 10.1152/physrev.00049.2009. [DOI] [PubMed] [Google Scholar]
  • 3.Williamson A, Spencer DD, Shepherd GN. Comparison between membrane and synaptic properties of the human and rodent granule cells. Brain Res. 1993;622:194–202. doi: 10.1016/0006-8993(93)90819-9. [DOI] [PubMed] [Google Scholar]
  • 4**.Du W, Bautista JF, Yang H, et al. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet. 2005;37:733–738. doi: 10.1038/ng1585. The D434G mutation in the BKCa channel α subunit KCNMA1 gene contributes to the development of idiopathic epilepsy in humans and gives rise to the channel gain-of-function mechanisms. [DOI] [PubMed] [Google Scholar]
  • 5.Salkoff L, Butler A, Ferreira G, et al. High-conductance potassium channels of the SLO family. Nat Rev Neurosci. 2006;7:921–931. doi: 10.1038/nrn1992. [DOI] [PubMed] [Google Scholar]
  • 6.Horrigan FT, Aldrich RW. Coupling between voltage sensor activation, Ca2+ binding and channel opening in large conductance (BK) potassium channel. J Gen Physiol. 2002;120:267–305. doi: 10.1085/jgp.20028605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brenner R, Jegla TJ, Wickenden A, et al. Cloning and functional characterization of novel large conductance calcium-activated potassium channel β-subunits, hKCNMB3 and hKCNMB4. J Biol Chem. 2000;275:6453–6461. doi: 10.1074/jbc.275.9.6453. [DOI] [PubMed] [Google Scholar]
  • 8.Pallanek L, Genetzky B. Cloning and characterization of human and mouse homologs of the Drosophila calcium-activated potassium channels gene slowpoke. Hum Mol Genet. 1994;3:1239–1243. doi: 10.1093/hmg/3.8.1239. [DOI] [PubMed] [Google Scholar]
  • 9.Wallner M, Meera P, Toro L. Determinant for beta-subunit regulation in high-conductance voltage-activated and Ca2+-sensitive K+ channels: an additional transmembrane region at the N-terminus. Proc Natl Acad Sci USA. 1996;93:14922–14927. doi: 10.1073/pnas.93.25.14922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ma Z, Lou XJ, Horrigan FT. Role of charged residues in the S1-S4 voltage sensor of BK channels. J Gen Physiol. 2006;127:309–28. doi: 10.1085/jgp.200509421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Díaz L, Meera P, Amigo J, et al. Role of the S4 segment in a voltage-dependent calcium sensitive potassium (hSlo) channel. J Biol Chem. 1998;273:32430–32436. doi: 10.1074/jbc.273.49.32430. [DOI] [PubMed] [Google Scholar]
  • 12.Wu Y, Xiong Y, Wang S, et al. Intersubunit coupling in the pore of BK channels. J Biol Chem. 2009;284:23353–23363. doi: 10.1074/jbc.M109.027789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13**.Yuan P, Leonetti MD, Pico AR, et al. Structure of the human BK channel Ca2+-activated apparatus at 3.0 A resolution. Science. 2010;329:182–187. doi: 10.1126/science.1190414. The authors describe the crystal structure of the human BKCa channel C-terminus. The BKCa channel has a gating ring that is formed by four pairs of RCK1 and RCK2 domains. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Schreiber M, Salkoff I. A novel calcium-sensing domain of the BK channel. Biophys J. 1997;73:1355–1363. doi: 10.1016/S0006-3495(97)78168-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wu Y, Yang Y, Ye S, et al. Structure of the gating ring from the human large-conductance Ca2+-activated K+ channel. Nature. 2010;466:393–397. doi: 10.1038/nature09252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wang L, Sigworth FJ. Structure of the BK potassium channel in a lipid membrane from electron cryomicroscopy. Nature. 2009;461:292–295. doi: 10.1038/nature08291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Xia XM, Zeng X, Lingle CJ. Multiple regulatory sites in large-conductance calcium-activated potassium channels. Nature. 2002;418:880–884. doi: 10.1038/nature00956. [DOI] [PubMed] [Google Scholar]
  • 18.Zhang G, Huang SY, Yang J, et al. Ion sensing in the RCK1 domain of BK channels. Proc Natl Acad Sci USA. 2010;107:18700–18705. doi: 10.1073/pnas.1010124107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yusifov T, Savalli N, Gandhi CS, et al. The RCK2 domain of the human BKCa channel is a calcium sensor. Proc Natl Acad Sci USA. 2008;105:376–381. doi: 10.1073/pnas.0705261105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zhang X, Solaro CR, Lingle CJ. Allosteric regulation of BK channel gating by Ca2+ and Mg2+ through a nonselective, low affinity divalent cation site. J Gen Physiol. 2001;118:607–636. doi: 10.1085/jgp.118.5.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Shi J, Krishnamoorthy G, Yang Y, et al. Mechanism of magnesium activation of calcium-activated potassium channels. Nature. 2002;418:876–880. doi: 10.1038/nature00941. [DOI] [PubMed] [Google Scholar]
  • 22.Yang H, Shi J, Zhang G, et al. Activation of Slo1 BK channels by Mg2+ coordination between the voltage sensor and RCK1 domains. Nat Struct Mol Biol. 2008;15:1152–1159. doi: 10.1038/nsmb.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Javaherian AD, Yusifov T, Pantazis A, et al. Metal-driven operation of the human large-conductance voltage- and Ca2+-dependent potassium channel (BK) gating ring apparatus. J Biol Chem. 2011;286:20701–20709. doi: 10.1074/jbc.M111.235234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Avdonin V, Tang XD, Hoshi T. Stimulatory action of internal proton on Slo1 BK channels. Biophys J. 2003;84:2969–2980. doi: 10.1016/S0006-3495(03)70023-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Brelidze TI, Magleby KL. Protons block BK channels by competitive inhibition with K+ and contribute to the limits of unitary currents at high voltages. J Gen Physiol. 2004;123:305–319. doi: 10.1085/jgp.200308951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hou S, Xu R, Heinemann SH, et al. Reciprocal regulation of the Ca2+ and H+ sensitivity in the SLO1 BK channel conferred by the RCK1 domain. Nat Struct Mol Biol. 2008;15:403–410. doi: 10.1038/nsmb.1398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhou XB, Wulfsen I, Utku E, et al. Dual role of protein kinase C on BK channels regulation. Proc Natl Acad Sci USA. 2011;107:8005–8010. doi: 10.1073/pnas.0912029107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Chen L, Tian L, MacDonald SHF, et al. Functionally diverse complement of large conductance calcium and voltage-activated potassium channel (BK) α-subunits generated from a single site of splicing. J Biol Chem. 2005;280:33599–33609. doi: 10.1074/jbc.M505383200. [DOI] [PubMed] [Google Scholar]
  • 29.Xie J, McCobb DP. Control of alternative splicing of potassium channels by stress hormones. Science. 1998;280:443–446. doi: 10.1126/science.280.5362.443. [DOI] [PubMed] [Google Scholar]
  • 30.Jiang Z, Wallner M, Meera P, et al. Human and rodent maxiK channel b-subunit genes: cloning and characterization. Genomics. 1999;55:57–67. doi: 10.1006/geno.1998.5627. [DOI] [PubMed] [Google Scholar]
  • 31.Yan J, Aldrich RW. LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium. Nature. 2010;466:513–516. doi: 10.1038/nature09162. [DOI] [PubMed] [Google Scholar]
  • 32.Lui G, Niu X, Wu RS, et al. Location of modulatory β subunits in BK potassium channels. J Gen Physiol. 2010;135:449–459. doi: 10.1085/jgp.201010417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Dworetzky SI, Boissard CG, Lum-Ragan JT, et al. Phenotypic alteration of a human BK (hSlo) channel by hSlobeta subunit coexpression: changes in blocker sensitivity, activation/relaxation and inactivation kinetics, and protein kinase A modulation. J Neurosci. 1996;16:4543–4550. doi: 10.1523/JNEUROSCI.16-15-04543.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Meera P, Wallner M, Toro L. A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin. Proc Natl Acad Sci USA. 2000;97:5562–5567. doi: 10.1073/pnas.100118597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lee US, Cui J. β-subunit-specific modulations of BK channels function by a mutation associated with epilepsy and dyskinesia. J Physiol. 2009;587:1481–1498. doi: 10.1113/jphysiol.2009.169243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wallner M, Meera P, Toro L. Molecular basis of fast inactivation in voltage and Ca2+-activated K+ channels: a transmembrane beta-subunit homolog. Proc Natl Acad Sci USA. 1999;96:4137–4142. doi: 10.1073/pnas.96.7.4137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hu S, Labuda MZ, Pandolfo M, et al. Variants of the KCNMB3 regulatory subunit of maxi BK channels affects channel inactivation. Physiol Genomics. 2003;15:191–198. doi: 10.1152/physiolgenomics.00110.2003. [DOI] [PubMed] [Google Scholar]
  • 38.Uebele VN, Laggrutta A, Wade T, et al. Cloning and functional expression of two families of β-subunits of the large conductance calcium-activated K+ channels. J Biol Chem. 2000;275:23211–23218. doi: 10.1074/jbc.M910187199. [DOI] [PubMed] [Google Scholar]
  • 39.Wang B, Rothberg BS, Brenner R. Mechanism of β4 subunit modulation of BK channels. J Gen Physiol. 2006;127:449–465. doi: 10.1085/jgp.200509436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Petrick D, Brenner R. Regulation of STREX exon large conductance, calcium-activated potassium channels by the β4 accessory subunit. Neuroscience. 2007;149:789–803. doi: 10.1016/j.neuroscience.2007.07.066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Knaus HG, Schwarzer C, Koch RO, et al. Distribution of high-conductance Ca2+-activated K+ channels in rat brain: targeting to axons and nerve terminals. J Neurosci. 1996;16:955–963. doi: 10.1523/JNEUROSCI.16-03-00955.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Matire M, Barrese V, D'Amico M, et al. Presynaptic BK channels selectively control glutamate versus GABA release from cortical and hippocampal nerve terminals. J Neurochem. 2010;115:411–422. doi: 10.1111/j.1471-4159.2010.06938.x. [DOI] [PubMed] [Google Scholar]
  • 43.Sailer CA, Kaufmann WA, Kogler M, et al. Immunolocalization of BK channels in hippocampal pyramidal neurons. Eur J Neurosci. 2006;24:442–454. doi: 10.1111/j.1460-9568.2006.04936.x. [DOI] [PubMed] [Google Scholar]
  • 44.Poolos NP, Johnston D. Calcium-activated potassium conductances contribute to action potential repolarization at the soma but not the dendrites of hippocampal CA1 pyramidal neurons. J Neurosci. 1999;19:5205–5212. doi: 10.1523/JNEUROSCI.19-13-05205.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Chang CP, Dworetzky SI, Wang J, et al. Differential expression of the alpha and beta subunits of the large-conductance calcium-activated potassium channel: implication for channel diversity. Brain Res Mol Brain Res. 1997;45:33–40. doi: 10.1016/s0169-328x(96)00230-6. [DOI] [PubMed] [Google Scholar]
  • 46.Sausbier U, Sausbier M, Sailer CA, et al. Ca2+ -activated K+ channels of the BK-type in the mouse brain. Histochem Cell Biol. 2006;125:725–741. doi: 10.1007/s00418-005-0124-7. [DOI] [PubMed] [Google Scholar]
  • 47.Douglas RM, Lai JC, Bian S, et al. The calcium-sensitive large-conductance potassium channel (BK/MAXI K) is present in the inner mitochondrial membrane of rat brain. Neuroscience. 2006;139:1249–1261. doi: 10.1016/j.neuroscience.2006.01.061. [DOI] [PubMed] [Google Scholar]
  • 48.Kulawiak B, Bednarczyk P. Reconstitution of brain mitochondria inner membrane into planar lipid bilayer. Acta Neurobiol Exp (Wars) 2005;65:271–276. doi: 10.55782/ane-2005-1562. [DOI] [PubMed] [Google Scholar]
  • 49.Soom M, Gessner G, Heuer H, et al. A mutually exclusive alternative exon of slo1 codes for a neuronal BK channel with altered function. Channels. 2008;2:278–282. doi: 10.4161/chan.2.4.6571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Behrens R, Nolting A, Reimann F, et al. hKCNMB3 and hKCNMB4, cloning and characterization of two members of the large-conductance calcium-activated potassium channel beta subunit family. FEBS Lett. 2000;474:99–106. doi: 10.1016/s0014-5793(00)01584-2. [DOI] [PubMed] [Google Scholar]
  • 51.Piwonska M, Wilczek E, Szewczyk A, et al. Differential distribution of Ca2+-activated potassium channel beta4 subunit in rat brain: immunolocalization in neuronal mitochondria. Neuroscience. 2008;153:446–60. doi: 10.1016/j.neuroscience.2008.01.050. [DOI] [PubMed] [Google Scholar]
  • 52**.Sanabria ERG, Su H, Yaari Y. Initiation of network bursts by Ca2+-dependent intrinsic bursting in the rat pilocarpine model of temporal lobe epilepsy. J Physiol. 2001;532:205–216. doi: 10.1111/j.1469-7793.2001.0205g.x. The authors report a dramatic de novo appearance of Ca2+-dependent bursting that contribute to epileptogenesis in a model of temporal lobe epilepsy. Thus, targeting Ca2+-dependent mechanisms may have therapeutic potentials. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Xion ZQ, Saggau P, Stringer JL. Activity-dependent intracellular acidification correlates with the duration of seizure activity. J Neurosci. 2000;20:1290–1296. doi: 10.1523/JNEUROSCI.20-04-01290.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Isaacson JS, Murphy GJ. Glutamate-mediated extrasynaptic inhibition: direct coupling of NMDA receptors to Ca2+-activated K+ channels. Neuron. 2001;31:1027–1034. doi: 10.1016/s0896-6273(01)00428-7. [DOI] [PubMed] [Google Scholar]
  • 55.Berkefeld H, Sailer CA, Bildl W, et al. BKCa-Cav channel complexes mediate rapid and localized Ca2+-activated K+ signaling. Science. 2006;314:615–620. doi: 10.1126/science.1132915. [DOI] [PubMed] [Google Scholar]
  • 56.Müller A, Kukley M, Uebachs M, et al. Nanodomains of single Ca2+ channels contribute to action potential repolarization in cortical neurons. J Neurosci. 2007;27:483–495. doi: 10.1523/JNEUROSCI.3816-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Chavis P, Ango F, Michel JM, et al. Modulation of big K+ channels activity by ryanodine receptors and L-type Ca2+ channels in neurons. Eur J Neurosci. 1998;10:2322–2327. doi: 10.1046/j.1460-9568.1998.00243.x. [DOI] [PubMed] [Google Scholar]
  • 58.Kaufmann WA, Kasugai Y, Ferraguti F, et al. Two distinct pools of large-conductance calcium-activated potassium channels in the somatic plasma membrane of central principal neurons. Neuroscience. 2010;169:974–86. doi: 10.1016/j.neuroscience.2010.05.070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Song X, Su W, Chen L, et al. Functional expression of large-conductance Ca2+-activated potassium channels in lateral globus pallidus neurons. Neuroscience. 2010;169:1548–1556. doi: 10.1016/j.neuroscience.2010.06.026. [DOI] [PubMed] [Google Scholar]
  • 60.Su W, Song X, Ji JJ. Functional expression of a large-conductance Ca2+-activated K+ channel in mouse substantia nigra pars compacta dopaminergic neurons. Neurosci Lett. 2010;471:1–5. doi: 10.1016/j.neulet.2009.12.058. [DOI] [PubMed] [Google Scholar]
  • 61.Xion ZQ, Saggau P, Stringer JL. Activity-dependent intracellular acidification correlates with the duration of seizure activity. J Neurosci. 2000;20:1290–1296. doi: 10.1523/JNEUROSCI.20-04-01290.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Hou S, Vigeland LE, Zhang G, et al. Zn2+ activates large conductance Ca2+-activated K+ channel via an intracellular domain. J Biol Chem. 2010;285:6434–6442. doi: 10.1074/jbc.M109.069211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Timofeeva O, Nadler JV. Facilitation of granule cell epileptiform activity by mossy fiber-released zinc in the pilocarpine model of temporal lobe epilepsy. Brain Res. 2006;1078:227–234. doi: 10.1016/j.brainres.2006.01.051. [DOI] [PubMed] [Google Scholar]
  • 64.Hermann A, Gorman AJ. Effects of tetraethylammonium on potassium currents in a molluscan neuron. J Gen Physiol. 1981;78:87–110. doi: 10.1085/jgp.78.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Guillemare E, Honore E, Pradier L, et al. Effects of the level of mRNA expression on biophysical properties, sensitivity to neurotoxins, and regulation of the brain delayed-rectifier K+ channel Kv1.2. Biochemistry. 1992;31:12463–12468. doi: 10.1021/bi00164a024. [DOI] [PubMed] [Google Scholar]
  • 66.Sones WR, Leblanc N, Greenwood IA. Inhibition of vascular calcium-gated chloride currents by blockers of KCa1.1, but not by modulators of KCa2.1 or KCa2.3 channels. Br J Pharmacol. 2009;158:521–531. doi: 10.1111/j.1476-5381.2009.00332.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Skalska J, Bednarczyk P, Piwońska M, et al. Calcium ions regulate K+ uptake into brain mitochondria: The evidence for a novel potassium channel. Int J Mol Sci. 2009;10:1104–1120. doi: 10.3390/ijms10031104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Garcia-Valdes J, Zamudio FZ, Toro L, et al. Slotoxin, alphaKT×1.11, a new scorpion peptide blocker of MaxiK channels that differentiates between a and a+P (β1 or β4) complexes. FEBS Lett. 2001;505:369–373. doi: 10.1016/s0014-5793(01)02791-0. [DOI] [PubMed] [Google Scholar]
  • 69.Crowley JJ, Treistman SN, Dopico AM. Cholesterol antagonizes ethanol potentiation of human brain BK channels reconstituted into phospholipid bilayers. Mol Pharmacol. 2003;64:365–373. doi: 10.1124/mol.64.2.365. [DOI] [PubMed] [Google Scholar]
  • 70.Bentzen BH, Nardi A, Calloe K, et al. The small molecule NS11021 is a potent specific activator of Ca2+-activated big conductance K+ channels. Mol Pharmacol. 2007;72:1033–1044. doi: 10.1124/mol.107.038331. [DOI] [PubMed] [Google Scholar]
  • 71.Sun X, Yao H, Zhou D, et al. Modulation of hslo BK current inactivation by fatty acid esters of CoA. J Neurochem. 2008;104:1394–1403. doi: 10.1111/j.1471-4159.2007.05083.x. [DOI] [PubMed] [Google Scholar]
  • 72.Lee JE, Kwak J, Suh C, et al. Dual effects of nitric oxide on the large conductance calcium-activated potassium channels of rat brain. J Biochem Mol Biol. 2006;39:91–96. doi: 10.5483/bmbrep.2006.39.1.091. [DOI] [PubMed] [Google Scholar]
  • 73.Nishimura I, Ui-Tei K, Saigo K, et al. 17β-estradiol at physiological concentration augments Ca2+-activated K+ currents via estrogen receptor β in the gonadotropin-releasing hormone neuronal cell line GT1-7. Endocrinology. 2008;149:774–782. doi: 10.1210/en.2007-0759. [DOI] [PubMed] [Google Scholar]
  • 74.Liu J, Vaithianathan T, Manivannan K, et al. Ethanol modulates BKCa channels by acting as an adjuvant of calcium. Mol Pharmacol. 2008;74:628–640. doi: 10.1124/mol.108.048694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Bond CT, Herson PS, Strassmaier T, et al. Small conductance Ca2+-activated K+ channel knock-out mice reveal the identity of calcium-dependent afterhyperpolarization currents. J Neurosci. 2004;24:5301–5306. doi: 10.1523/JNEUROSCI.0182-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Faber ES, Sah P. Ca2+-activated K+ (BK) channel inactivation contributes to spike broadening during repetitive firing in the rat lateral amygdala. J Physiol. 2003;2:552. 483–497. doi: 10.1113/jphysiol.2003.050120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Hu H, Shao LR, Chavoshy S, et al. Presynaptic Ca2+-activated K+ channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release. J Neurosci. 2001;21:9585–9597. doi: 10.1523/JNEUROSCI.21-24-09585.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Rundén-Pran E, Haug FM, Storm JF, et al. BK channel activity determines the extent of cell degeneration after oxygen and glucose deprivation: a study in organotypical hippocampal slice cultures. Neuroscience. 2002;112:277–288. doi: 10.1016/s0306-4522(02)00092-1. [DOI] [PubMed] [Google Scholar]
  • 79.Shao LR, Halvorsrud R, Borg-Graham L, et al. The role of BK-type Ca2+-dependent K+ channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells. J Physiol. 1999;521:135–146. doi: 10.1111/j.1469-7793.1999.00135.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80**.Gu N, Vervaeke K, Storm JF. BK potassium channels facilitate high-frequency firing and cause early frequency adaptation in rat CA1 hippocampal pyramidal cells. J Physiol. 2007;580:859–882. doi: 10.1113/jphysiol.2006.126367. Extracellular field recordings show that BKCa channels contribute to high frequency burst firing in response to strong depolarizing current. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81**.Brenner R, Chen QH, Vilaythong A, et al. BK channel β4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat Neurosci. 2005;8:1752–1759. doi: 10.1038/nn1573. Genetic deletion of BKCa channel β4 subunit gives rise to the channel gain-of-function mechanisms associated with temporal lobe seizures. [DOI] [PubMed] [Google Scholar]
  • 82**.Jin W, Sugaya A, Tsuda T, et al. Relationship between large conductance calcium-activated potassium channel and bursting activity. Brain Res. 2000;860:21–28. doi: 10.1016/s0006-8993(00)01943-0. The authors report that BKCa channels contribute to bursting activity. Interestingly, blockade these channels suppresses epileptiform bursting in various models of acute seizures. [DOI] [PubMed] [Google Scholar]
  • 83.Wang B, Rothberg BS, Brenner R. Mechanism of increased BK channel activation from channel mutation that causes epilepsy. J Gen Physiol. 2009;133:283–294. doi: 10.1085/jgp.200810141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Yang J, Krishnamoorthy G, Saxena A, et al. An epilepsy/dyskinesia-associated mutation enhances BK channel activation by potentiating Ca2+ sensing. Neuron. 2010;66:871–883. doi: 10.1016/j.neuron.2010.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Cavalleri GL, Weale ME, Shianna KV, et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol. 2007;6:970–980. doi: 10.1016/S1474-4422(07)70247-8. [DOI] [PubMed] [Google Scholar]
  • 86.Riazi MA, Brinkman-Mills P, Jonhson A, et al. Identification of a putative regulatory subunit of a calcium-activated potassium channel in the dup(3q) syndrome region and a related sequence on 22q11. 2 Genomics. 1999;62:90–94. doi: 10.1006/geno.1999.5975. [DOI] [PubMed] [Google Scholar]
  • 87.Sander T, Schulz H, Saar K, et al. Genome search for susceptibility loci of common idiopathic generalized epilepsies. Hum Mol Genet. 2000;9:1465–1472. doi: 10.1093/hmg/9.10.1465. [DOI] [PubMed] [Google Scholar]
  • 88**.Lorenz S, Heils A, Kasper JM, et al. Allelic association of a truncation mutation of the KCNMB3 gene with idiopathic generalized epilepsy. Am J Med Genetics. 2007;144B:10–13. doi: 10.1002/ajmg.b.30369. This study reveals an allelic association with of the KCNMB3 delA750 mutation with common idiopathic generalized epilepsy, particularly absence epilepsy. [DOI] [PubMed] [Google Scholar]
  • 89.Ermolinsky B, Skinner F, Garcia I, et al. Upregulation of STREX splice variant of the large conductance Ca2+-activated potassium (BK) channel in a rat model of mesial temporal lobe epilepsy. Neurosci Res. 2011;69:73–80. doi: 10.1016/j.neures.2010.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Kudin AP, Zsurka G, Elger CE, Kunz WS. Mitochondrial involvement in temporal lobe epilepsy. Exp Neurol. 2009;218:326–332. doi: 10.1016/j.expneurol.2009.02.014. [DOI] [PubMed] [Google Scholar]
  • 91.Bindokas VP, Lee CC, Colmers WF, et al. Changes in mitochondrial function resulting from synaptic activity in the rat hippocampal slice. J Neurosci. 1998;18:4570–4587. doi: 10.1523/JNEUROSCI.18-12-04570.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Rong Y, Doctrow SR, Tocco G, et al. EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology. Proc Natl Acad Sci USA. 1999;96:9897–9902. doi: 10.1073/pnas.96.17.9897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93*.Shruti S, Clem LR, Barth AL. A seizure-induced gain-of-function in BK channels is associated with elevated firing activity in neocortical pyramidal neurons. Neurobiol Dis. 2008;30:323–330. doi: 10.1016/j.nbd.2008.02.002. Picrotoxin-induced generalized tonic-clonic seizures give rise to BKCa channels gain-of-function mechanisms in pyramidal neurons of primary somatosensory (barrel) cortex. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Sheehan JJ, Benedetti BL, Barth AL. Anticonvulsant effects of the BK-channel antagonist paxilline. Epilepsia. 2009;50:711–720. doi: 10.1111/j.1528-1167.2008.01888.x. [DOI] [PubMed] [Google Scholar]
  • 95*.Verma-Ahuja S, Evans MS, Espinosa JA. Evidence of increased excitability in GEPR hippocampus preceding development of seizure susceptibility. Epilepsy Res. 1995;31:161–173. doi: 10.1016/s0920-1211(98)00027-8. Inherited loss-of-function BKCa channels may contribute to the pathophysiology of inherited seizure susceptibility in the genetically epilepsy-prone rats. [DOI] [PubMed] [Google Scholar]
  • 96.N'Gouemo P, Yasuda RP, Faingold CL. Protein expression of small conductance calcium-activated potassium channels is altered in inferior colliculus neurons of the genetically epilepsy-prone rat. Brain Res. 2009;1270:107–111. doi: 10.1016/j.brainres.2009.02.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97**.Pacheco Otalora LF, Hernandez EF, Arshadmansab MF, et al. Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy. Brain Res. 2008;1200:116–131. doi: 10.1016/j.brainres.2008.01.017. Downregulation of BKCa channel proteins is associated with the development of temporal lobe epilepsy. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98**.Ermolinsky B, Arshadmansab MF, Patcheco Otalora LF, et al. Deficit of Kcnma1 mRNA expression in the dentate gyrus of epileptic rats. Neuro Report. 2008;18:1291–1294. doi: 10.1097/WNR.0b013e3283094bb6. Downregulation of the gene encoding for BKCa channel α subunit is associated with the development of temporal lobe epilepsy. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99**.Young KL, Villar D, Carson TL, et al. Tremorgenic mycotoxin intoxication with penitrem A and roquefortine in two dogs. J Am Vet Med Assoc. 2003;222:52–53. doi: 10.2460/javma.2003.222.52. The authors report that BKCa channels blockade triggers seizures and status epilepticus, providing a compelling evidence of the role of these channels in seizure etiology. [DOI] [PubMed] [Google Scholar]
  • 100.Crunelli V, Leresche N. Block of thalamic T-type Ca2+ channels by ethosuximide is not the whole story. Epilepsy Curr. 2002;2:53–56. doi: 10.1046/j.1535-7597.2002.00024.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES